Sana Biotechnology Inc (SANA)

$3.93 -0.16 (-3.91%)
Market Cap 1.25B
Revenue (ttm) 0.00
Net Income (ttm) -244.17M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 2,142,808
Avg Vol 3,013,606
Day's Range N/A - N/A
Shares Out 299.36M
Stochastic %K 83%
Beta 2.16
Analysts Strong Sell
Price Target $9.38

Company Profile

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company's product pipeline includes UP421, a HIP-modified allogeneic primary islet cell product, which is in phase 1 clinical trial to treat type 1 diabetes; SC451, a HIP-modifi...

Industry: Biotechnology
Sector: Healthcare
Phone: 206 701 7914
Address:
188 East Blaine Street, Suite 400, Seattle, United States
mirko_papuga
mirko_papuga Aug. 28 at 8:33 PM
$SANA Picked up another 315 shares today on the dip. Share price will probably go down once Mayo exercises/does dilution, but either way I'm in for 315 more.
0 · Reply
Inflames_swe
Inflames_swe Aug. 28 at 7:28 PM
$SANA is it possible for us to see the mayobuy if it happens today?
1 · Reply
mirko_papuga
mirko_papuga Aug. 28 at 4:41 AM
$SANA Ran into these two articles as part of the EU's CORDIS Horizon 2020 Project.. exciting for anyone with T1D or knows of anyone with T1D. Project Information: VANGUARD New Generation Cell Therapy: Bioartificial pancreas offers a potential cure for type 1 diabetes https://cordis.europa.eu/article/id/464698-bioartificial-pancreas-offers-a-potential-cure-for-type-1-diabetes Total cost: € 6 844 625,00 Coordinated by: UNIVERSITE DE GENEVE, Switzerland Project Information: ISLET Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe https://cordis.europa.eu/article/id/466194-transforming-diabetes-care-through-stem-cell-based-therapies Total cost: € 7 999 998,75 Coordinated by HELMHOLTZ ZENTRUM MUENCHEN..., Germany At the time of posting, I have not looked into the details of these project details, how far along they are or if SANA may be involved in any way. Also, not sure if some of these projects are related to the upcoming presentation SANA has for 20 minutes on October 2, 2026 at the symposium of the European Association for the Study of Diabetes (EASD) Annual Meeting 2026 taking place from September 28 - October 2, 2026 in Milan, Italy.
2 · Reply
BiotechButterflies
BiotechButterflies Aug. 27 at 10:09 PM
$SANA ... up and down.. But once ready for clinic... BOOM!... such neat solution to T1D... i alreadt accumulated... now wait for the news
1 · Reply
LoveRetailFroth
LoveRetailFroth Aug. 27 at 2:41 PM
$SANA Hold your HIP shorties 😂🤣 SQUEEZE ! $10 plus 🚀
0 · Reply
CapitalMonk
CapitalMonk Aug. 26 at 8:58 PM
$SANA Price: $4.16 (+1.46%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±1.10% RSI: 66.2 | Momentum: Strong Momentum Volume: -9.2% vs avg Volatility: 4.98% Support: $3.05 | Resistance: $4.19 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
BBraggHillBoys
BBraggHillBoys Aug. 26 at 7:58 PM
$SANA when are short positions going to lose conviction? The stock continues to climb on average volume.
1 · Reply
LoveRetailFroth
LoveRetailFroth Aug. 26 at 6:07 PM
$SANA REVOLUTIONARY HIP 10X atleast 🚀💎
0 · Reply
LoveRetailFroth
LoveRetailFroth Aug. 26 at 5:09 PM
$SANA Nearly 25% SHORT! 45 MILLION shares to be covered. 18-20 DAYS to cover🚀
0 · Reply
LoveRetailFroth
LoveRetailFroth Aug. 26 at 1:47 PM
$AMLX Good Morning ☕️ Lucky Bastards got in or added😂💎 $RXRX $SANA $ARBE
0 · Reply
Latest News on SANA
Sana Biotechnology price target lowered to $6 from $7 at BofA

2026-08-16T13:45:39.000Z - 12 days ago

Sana Biotechnology price target lowered to $6 from $7 at BofA

Sana Biotechnology reports Q2 EPS (13c), consensus (12c)

2026-08-10T20:46:01.000Z - 18 days ago

Sana Biotechnology reports Q2 EPS (13c), consensus (12c)

Sana Biotechnology Earnings release: Q2 2026

Aug 10, 2026, 4:00 PM EDT - 18 days ago

Sana Biotechnology Earnings release: Q2 2026

Sana Biotechnology Quarterly report: Q2 2026

Aug 10, 2026, 4:00 PM EDT - 18 days ago

Sana Biotechnology Quarterly report: Q2 2026

Sana Biotechnology Slides: Corporate presentation

Aug 10, 2026, 7:00 AM EDT - 18 days ago

Sana Biotechnology Slides: Corporate presentation

Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Jul 29, 2026, 10:09 AM EDT - 4 weeks ago

Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Sana Biotechnology announces publication of long-term diabetes data

2026-07-13T13:30:18.000Z - 6 weeks ago

Sana Biotechnology announces publication of long-term diabetes data

Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes

Jul 13, 2026, 8:00 AM EDT - 6 weeks ago

Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes

Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026

Jul 1, 2026, 9:00 AM EDT - 2 months ago

Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026

Sana Biotechnology Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 9, 2026, 4:00 PM EDT - 2 months ago

Sana Biotechnology Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Sana Biotechnology Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 9:20 AM EDT - 3 months ago

Sana Biotechnology Transcript: Jefferies Global Healthcare Conference 2026

Sana Biotechnology to Present at June 2026 Investor Conferences

May 27, 2026, 4:05 PM EDT - 3 months ago

Sana Biotechnology to Present at June 2026 Investor Conferences

Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility

May 15, 2026, 9:00 AM EDT - 3 months ago

Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility

Sana Biotechnology presents preclinical data for in vivo CAR T cell therapy

2026-05-12T22:28:22.000Z - 3 months ago

Sana Biotechnology presents preclinical data for in vivo CAR T cell therapy

Sana Biotechnology Transcript: Bank of America Global Healthcare Conference 2026

May 12, 2026, 5:20 PM EDT - 3 months ago

Sana Biotechnology Transcript: Bank of America Global Healthcare Conference 2026

Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs

May 12, 2026, 4:05 PM EDT - 3 months ago

Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs

Sana Biotechnology reports Q1 non-GAAP EPS (14c), consensus (15c)

2026-05-11T20:42:28.000Z - 3 months ago

Sana Biotechnology reports Q1 non-GAAP EPS (14c), consensus (15c)

Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates

May 11, 2026, 4:05 PM EDT - 3 months ago

Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates

Sana Biotechnology Earnings release: Q1 2026

May 11, 2026, 4:00 PM EDT - 3 months ago

Sana Biotechnology Earnings release: Q1 2026

Sana Biotechnology Quarterly report: Q1 2026

May 11, 2026, 4:00 PM EDT - 3 months ago

Sana Biotechnology Quarterly report: Q1 2026

Sana Biotechnology Slides: Corporate presentation

May 11, 2026, 4:00 PM EDT - 3 months ago

Sana Biotechnology Slides: Corporate presentation

Sana Biotechnology initiated with a Buy at Rodman & Renshaw

2026-05-11T17:02:47.000Z - 3 months ago

Sana Biotechnology initiated with a Buy at Rodman & Renshaw

Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference

May 5, 2026, 4:05 PM EDT - 4 months ago

Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference

Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting

Apr 27, 2026, 4:30 PM EDT - 4 months ago

Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting

Sana Biotechnology Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Sana Biotechnology Proxy statement: Proxy filing

Sana Biotechnology Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Sana Biotechnology Proxy statement: Proxy filing

Sana Biotechnology price target raised to $7 from $6 at Wedbush

2026-04-14T13:23:10.000Z - 4 months ago

Sana Biotechnology price target raised to $7 from $6 at Wedbush

Sana Biotechnology announces SC451 strategic collaboration with Mayo Clinic

2026-04-13T20:18:08.000Z - 4 months ago

Sana Biotechnology announces SC451 strategic collaboration with Mayo Clinic

Sana Biotechnology Slides: Corporate presentation

Apr 13, 2026, 7:00 AM EDT - 4 months ago

Sana Biotechnology Slides: Corporate presentation

Sana announces follow-up results from first-in-human study transplanting UP421

2026-03-13T13:10:51.000Z - 6 months ago

Sana announces follow-up results from first-in-human study transplanting UP421

Sana Biotechnology Transcript: The Citizens Life Sciences Conference 2026

Mar 11, 2026, 1:40 PM EDT - 6 months ago

Sana Biotechnology Transcript: The Citizens Life Sciences Conference 2026

Sana Biotechnology files automatic mixed securities shelf

2026-03-03T22:25:38.000Z - 6 months ago

Sana Biotechnology files automatic mixed securities shelf

Sana Biotechnology reports Q4 EPS (16c), consensus (13c)

2026-03-03T21:25:24.000Z - 6 months ago

Sana Biotechnology reports Q4 EPS (16c), consensus (13c)

Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Mar 3, 2026, 4:05 PM EST - 6 months ago

Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Sana Biotechnology Annual report: Q4 2025

Mar 3, 2026, 3:00 PM EST - 6 months ago

Sana Biotechnology Annual report: Q4 2025

Sana Biotechnology Earnings release: Q4 2025

Mar 3, 2026, 3:00 PM EST - 6 months ago

Sana Biotechnology Earnings release: Q4 2025

Sana Biotechnology Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 1:10 PM EST - 6 months ago

Sana Biotechnology Transcript: TD Cowen 46th Annual Health Care Conference

Sana Biotechnology to Present at March 2026 Investor Conferences

Feb 23, 2026, 4:05 PM EST - 6 months ago

Sana Biotechnology to Present at March 2026 Investor Conferences

Sana Biotechnology appoints Piper as EVP, CFO

2026-02-17T14:16:15.000Z - 6 months ago

Sana Biotechnology appoints Piper as EVP, CFO

Sana Biotechnology Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 12:45 PM EST - 8 months ago

Sana Biotechnology Transcript: 44th Annual J.P. Morgan Healthcare Conference

Sana Biotechnology Slides: Corporate presentation

Jan 14, 2026, 12:00 PM EST - 8 months ago

Sana Biotechnology Slides: Corporate presentation

Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

Jan 7, 2026, 4:26 PM EST - 8 months ago

Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

Sana Biotechnology price target raised to $7 from $6 at BofA

2026-01-06T15:25:24.000Z - 8 months ago

Sana Biotechnology price target raised to $7 from $6 at BofA

Sana Biotechnology announces publication of in vivo gene editing

2025-12-08T14:05:59.000Z - 9 months ago

Sana Biotechnology announces publication of in vivo gene editing

Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform

Dec 8, 2025, 9:00 AM EST - 9 months ago

Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform

Sana Biotechnology Transcript: Evercore ISI 8th Annual HealthCONx Conference

Dec 3, 2025, 2:35 PM EST - 9 months ago

Sana Biotechnology Transcript: Evercore ISI 8th Annual HealthCONx Conference

Sana Biotechnology Transcript: Citi Annual Global Healthcare Conference 2025

Dec 2, 2025, 2:30 PM EST - 9 months ago

Sana Biotechnology Transcript: Citi Annual Global Healthcare Conference 2025

Sana Biotechnology to Present at December 2025 Investor Conferences

Nov 24, 2025, 4:05 PM EST - 9 months ago

Sana Biotechnology to Present at December 2025 Investor Conferences

Sana Biotechnology Transcript: TD Cowen Immunology and Inflammation Summit

Nov 12, 2025, 1:30 PM EST - 10 months ago

Sana Biotechnology Transcript: TD Cowen Immunology and Inflammation Summit

Sana Biotechnology reports Q3 EPS (16c), consensus (19c)

2025-11-06T23:25:54.000Z - 10 months ago

Sana Biotechnology reports Q3 EPS (16c), consensus (19c)

Sana Biotechnology Earnings release: Q3 2025

Nov 6, 2025, 7:00 AM EST - 10 months ago

Sana Biotechnology Earnings release: Q3 2025

Sana Biotechnology Quarterly report: Q3 2025

Nov 6, 2025, 7:00 AM EST - 10 months ago

Sana Biotechnology Quarterly report: Q3 2025

Sana Biotechnology Slides: Investor Presentation

Nov 5, 2025, 6:00 PM EST - 10 months ago

Sana Biotechnology Slides: Investor Presentation

Sana Biotechnology price target raised to $8 from $5 at Citizens JMP

2025-10-30T10:25:41.000Z - 10 months ago

Sana Biotechnology price target raised to $8 from $5 at Citizens JMP

Sana Biotechnology strength attributed to EMJ Capital long call

2025-10-15T17:45:20.000Z - 11 months ago

Sana Biotechnology strength attributed to EMJ Capital long call

Wedbush bullish on Sana Biotechnology, initiates with an Outperform

2025-09-24T11:45:09.000Z - 1 year ago

Wedbush bullish on Sana Biotechnology, initiates with an Outperform

Sana Biotechnology Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 9, 2025, 9:30 AM EDT - 1 year ago

Sana Biotechnology Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sana Biotechnology Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 8, 2025, 11:30 AM EDT - 1 year ago

Sana Biotechnology Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sana Biotechnology Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Sep 4, 2025, 8:00 AM EDT - 1 year ago

Sana Biotechnology Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Sana Biotechnology Transcript: Citi's Biopharma Back to School Conference

Sep 2, 2025, 3:15 PM EDT - 1 year ago

Sana Biotechnology Transcript: Citi's Biopharma Back to School Conference

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

Aug 28, 2025, 8:00 AM EDT - 1 year ago

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

FHTX IQV MRNA

Sana Biotechnology to Present at September 2025 Investor Conferences

Aug 26, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology to Present at September 2025 Investor Conferences

Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares

Aug 20, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares

Sana Biotechnology Quarterly report: Q2 2025

Aug 11, 2025, 12:30 PM EDT - 1 year ago

Sana Biotechnology Quarterly report: Q2 2025

Sana Biotechnology Earnings release: Q2 2025

Aug 11, 2025, 12:30 PM EDT - 1 year ago

Sana Biotechnology Earnings release: Q2 2025

Sana Biotechnology Announces Pricing of Public Offering

Aug 6, 2025, 11:24 PM EDT - 1 year ago

Sana Biotechnology Announces Pricing of Public Offering

Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Aug 6, 2025, 4:38 PM EDT - 1 year ago

Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

Aug 6, 2025, 7:00 AM EDT - 1 year ago

Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

MCRB

Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes

Aug 4, 2025, 11:35 AM EDT - 1 year ago

Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes

Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Jun 23, 2025, 10:05 AM EDT - 1 year ago

Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Sana Biotechnology Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 10, 2025, 8:40 AM EDT - 1 year ago

Sana Biotechnology Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions

Jun 9, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions

Sana Biotechnology Transcript: Jefferies Global Healthcare Conference 2025

Jun 4, 2025, 2:35 PM EDT - 1 year ago

Sana Biotechnology Transcript: Jefferies Global Healthcare Conference 2025

Sana Biotechnology Slides: Corporate Presentation

Jun 3, 2025, 7:00 AM EDT - 1 year ago

Sana Biotechnology Slides: Corporate Presentation

Sana Biotechnology to Present at June 2025 Investor Conferences

May 28, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology to Present at June 2025 Investor Conferences

Sana Biotechnology Transcript: BofA Securities 2025 Healthcare Conference

May 13, 2025, 12:20 PM EDT - 1 year ago

Sana Biotechnology Transcript: BofA Securities 2025 Healthcare Conference

Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference

May 12, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference

Sana Biotechnology Earnings release: Q1 2025

May 8, 2025, 4:00 PM EDT - 1 year ago

Sana Biotechnology Earnings release: Q1 2025

Sana Biotechnology Quarterly report: Q1 2025

May 8, 2025, 4:00 PM EDT - 1 year ago

Sana Biotechnology Quarterly report: Q1 2025

Sana Biotechnology Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Sana Biotechnology Proxy statement: Proxy Filing

Sana Biotechnology Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Sana Biotechnology Proxy statement: Proxy Filing

Sana Biotechnology Annual report: Q4 2024

Mar 17, 2025, 5:00 PM EDT - 1 year ago

Sana Biotechnology Annual report: Q4 2024

Sana Biotechnology Earnings release: Q4 2024

Mar 17, 2025, 5:00 PM EDT - 1 year ago

Sana Biotechnology Earnings release: Q4 2024

Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Mar 17, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

mirko_papuga
mirko_papuga Aug. 28 at 8:33 PM
$SANA Picked up another 315 shares today on the dip. Share price will probably go down once Mayo exercises/does dilution, but either way I'm in for 315 more.
0 · Reply
Inflames_swe
Inflames_swe Aug. 28 at 7:28 PM
$SANA is it possible for us to see the mayobuy if it happens today?
1 · Reply
mirko_papuga
mirko_papuga Aug. 28 at 4:41 AM
$SANA Ran into these two articles as part of the EU's CORDIS Horizon 2020 Project.. exciting for anyone with T1D or knows of anyone with T1D. Project Information: VANGUARD New Generation Cell Therapy: Bioartificial pancreas offers a potential cure for type 1 diabetes https://cordis.europa.eu/article/id/464698-bioartificial-pancreas-offers-a-potential-cure-for-type-1-diabetes Total cost: € 6 844 625,00 Coordinated by: UNIVERSITE DE GENEVE, Switzerland Project Information: ISLET Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe https://cordis.europa.eu/article/id/466194-transforming-diabetes-care-through-stem-cell-based-therapies Total cost: € 7 999 998,75 Coordinated by HELMHOLTZ ZENTRUM MUENCHEN..., Germany At the time of posting, I have not looked into the details of these project details, how far along they are or if SANA may be involved in any way. Also, not sure if some of these projects are related to the upcoming presentation SANA has for 20 minutes on October 2, 2026 at the symposium of the European Association for the Study of Diabetes (EASD) Annual Meeting 2026 taking place from September 28 - October 2, 2026 in Milan, Italy.
2 · Reply
BiotechButterflies
BiotechButterflies Aug. 27 at 10:09 PM
$SANA ... up and down.. But once ready for clinic... BOOM!... such neat solution to T1D... i alreadt accumulated... now wait for the news
1 · Reply
LoveRetailFroth
LoveRetailFroth Aug. 27 at 2:41 PM
$SANA Hold your HIP shorties 😂🤣 SQUEEZE ! $10 plus 🚀
0 · Reply
CapitalMonk
CapitalMonk Aug. 26 at 8:58 PM
$SANA Price: $4.16 (+1.46%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±1.10% RSI: 66.2 | Momentum: Strong Momentum Volume: -9.2% vs avg Volatility: 4.98% Support: $3.05 | Resistance: $4.19 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
BBraggHillBoys
BBraggHillBoys Aug. 26 at 7:58 PM
$SANA when are short positions going to lose conviction? The stock continues to climb on average volume.
1 · Reply
LoveRetailFroth
LoveRetailFroth Aug. 26 at 6:07 PM
$SANA REVOLUTIONARY HIP 10X atleast 🚀💎
0 · Reply
LoveRetailFroth
LoveRetailFroth Aug. 26 at 5:09 PM
$SANA Nearly 25% SHORT! 45 MILLION shares to be covered. 18-20 DAYS to cover🚀
0 · Reply
LoveRetailFroth
LoveRetailFroth Aug. 26 at 1:47 PM
$AMLX Good Morning ☕️ Lucky Bastards got in or added😂💎 $RXRX $SANA $ARBE
0 · Reply
BBraggHillBoys
BBraggHillBoys Aug. 26 at 10:27 AM
$SANA With roughly 10 million people worldwide living with Type 1 diabetes and about 500,000 new diagnoses each year, SC451 is targeting a massive and continually replenishing global market where even modest penetration could translate into blockbuster-scale revenue potential.
0 · Reply
JerryMalone32
JerryMalone32 Aug. 26 at 6:57 AM
$SANA https://www.biopharminternational.com/view/manufacturing-scale-safety-profiles-reimbursement-critical-hurdles-type-1-diabetes-cell-therapy
1 · Reply
mirko_papuga
mirko_papuga Aug. 25 at 9:56 PM
$SANA Started a position in $SLS today. Waiting after Aug 31/26 to pick up a bit more $SANA shares. Well done to everyone holding onto their $SANA shares.
2 · Reply
BBraggHillBoys
BBraggHillBoys Aug. 25 at 8:11 PM
$SANA Bullish catalyst if Mayo exercises its option.
0 · Reply
BriOnH
BriOnH Aug. 25 at 6:43 PM
$SANA 6 more days, by or on Aug 31, is the deadline for Mayo to exercise their option to buy 25m more shares at $3.33. I think it's safe to assume Mayo will be running Sana's phase 1/2 trial, but were they expecting a milestone to be hit before Aug 31?
1 · Reply
BBraggHillBoys
BBraggHillBoys Aug. 25 at 3:41 PM
$SANA hanging here like a champ!
0 · Reply
PastaSlobCFA
PastaSlobCFA Aug. 25 at 2:34 PM
$SANA quick squeeze to $10.00 please!!
0 · Reply
ConsulHorkos
ConsulHorkos Aug. 25 at 2:29 PM
$SANA nice pop today.
0 · Reply
LoveRetailFroth
LoveRetailFroth Aug. 25 at 2:10 PM
$RXRX Good Morning 💎 s☕️ $SANA $ARBE $AMLX
0 · Reply
LoveRetailFroth
LoveRetailFroth Aug. 24 at 1:58 PM
$RXRX Good SILLY Morning ☕️ $SANA $ARBE Stellar as usual is $AMLX as we make our way to $50 plus
0 · Reply
Cheesyisi
Cheesyisi Aug. 24 at 4:42 AM
$SANA
0 · Reply
LoveRetailFroth
LoveRetailFroth Aug. 22 at 2:41 PM
$AMLX Good Saturday Morning Folks☕️ I posted when I was down 15% last couple of weeks, so why not post when I am up😂 My portfolio grew an astonishing 30% last week finally achieving positive returns for the yr thanks to this 💎, $RXRX $SANA & $TEM $MRNA I see more crazy upside in all these next week. GL & have a great weekend!
0 · Reply